{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-341283","form_type":"8-K","ticker":"AVIR","cik":"0001593899","company_name":"Atea Pharmaceuticals, Inc.","filed_at":"2021-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.199637+00:00","generated_at":"2026-06-28T05:18:33.501700+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Atea cancels CEO's fireside chat at Evercore ISI HealthCONx Conference","bullets":["On Nov 22, Atea announced CEO Jean-Pierre Sommadossi would participate in a fireside chat at the 4th Annual Evercore ISI HealthCONx Conference on Dec 1, 2021.","On Nov 26, Atea determined it will not participate in that fireside chat; no webcast or recording will be available.","No reason for cancellation was provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-341283","json":"https://secwatch.observer/filing/0001193125-21-341283.json","markdown":"https://secwatch.observer/filing/0001193125-21-341283.md","text":"https://secwatch.observer/filing/0001193125-21-341283.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1593899/000119312521341283/0001193125-21-341283-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1593899/000119312521341283/d260834d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:18:33.501700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}